MiMedx Group, Inc.
MiMedx Group, Inc. logo
MDXG

MiMedx Group, Inc. (MDXG)

$3.43.98%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$3.2
Day's Range
$3.4
$2.59
52-Week Range
$7.64
1 month return14.86%
3 month return0.58%
1 year return52.71%
5 year return70.69%

Company Information

MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, the cinoany has both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The company derives its products from human placental tissues and process these tissues using its proprietary processing methods, including the PURION® process. The company employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx has supplied over two million allografts, through both direct and consignment shipments.
OrganizationMiMedx Group, Inc.
Employees811
CEOMr. K. Todd Newton
IndustryBiotechnology

Analyst Recommendation

based on 2 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 2 Wall street analysts offering stock ratings for MiMedx Group, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 201.47%

Current

$3.4

Target

$10.25

Recommendation Trend

Based on 2 analyst

Current1M Ago3M Ago
Buy
2
7
7
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
371.7M
Book Value
$0.0
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.17
PEG Ratio
2.97
Wall Street Target Price
10.25

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
82.49
Enterprise Value
422.4M
Enterprise Value/Revenue
1.62
Enterprise Value/Ebitda
-22.78

Technicals

Beta
1.73
50 Day MA
2.99
200 Day MA
3.75

Institutional Holdings

Essex Woodlands Health Ventures

20.6%

Vanguard Group Inc

5.29%

State Street Corporation

3.38%

Federated Hermes Inc

2.31%

Richmond Brothers Inc

2.2%

Geode Capital Management, LLC

1.56%

Discover more

Frequently Asked Questions

What is MiMedx Group, Inc. share price today?

Can Indians buy MiMedx Group, Inc. shares?

How can I buy MiMedx Group, Inc. shares from India?

Can Fractional shares of MiMedx Group, Inc. be purchased?

What are the documents required to start investing in MiMedx Group, Inc. stocks?

What are today’s High and Low prices of MiMedx Group, Inc.?

What are today’s traded volumes of MiMedx Group, Inc.?

What is today’s market capitalisation of MiMedx Group, Inc.?

What is the 52 Week High and Low Range of MiMedx Group, Inc.?

How much percentage MiMedx Group, Inc. is down from its 52 Week High?

How much percentage MiMedx Group, Inc. is up from its 52 Week low?

What are the historical returns of MiMedx Group, Inc.?

Who is the Chief Executive Officer (CEO) of MiMedx Group, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*